PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,124 | +11.2% | 3,600 | -19.8% | 0.00% | 0.0% |
| Q3 2022 | $10,000 | +42.9% | 4,489 | +68.2% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | -61.1% | 2,669 | -57.4% | 0.00% | -50.0% |
| Q1 2022 | $18,000 | -58.1% | 6,269 | -56.7% | 0.00% | -33.3% |
| Q4 2021 | $43,000 | +65.4% | 14,469 | +441.9% | 0.00% | 0.0% |
| Q3 2020 | $26,000 | +2500.0% | 2,670 | +2125.0% | 0.00% | – |
| Q2 2020 | $1,000 | -98.6% | 120 | -97.9% | 0.00% | -100.0% |
| Q2 2019 | $71,000 | +163.0% | 5,600 | +648.7% | 0.01% | +133.3% |
| Q1 2017 | $27,000 | -90.9% | 748 | -83.1% | 0.00% | -90.9% |
| Q3 2016 | $296,000 | +61.7% | 4,424 | -28.3% | 0.03% | +73.7% |
| Q2 2016 | $183,000 | +96.8% | 6,167 | +670.9% | 0.02% | +11.8% |
| Q2 2015 | $93,000 | +365.0% | 800 | +300.0% | 0.02% | +240.0% |
| Q1 2014 | $20,000 | -35.5% | 200 | -33.3% | 0.01% | -66.7% |
| Q4 2013 | $31,000 | – | 300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |